We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.56B
AUM Growth
-$353M
Cap. Flow
+$6.51M
Cap. Flow %
0.12%
Top 10 Hldgs %
25.14%
Holding
166
New
27
Increased
60
Reduced
40
Closed
11

Top Buys

Rank Stock Value
1
TMDX icon
Transmedics
TMDX
+$61.8M
2
MNDY icon
monday.com
MNDY
+$34.2M
3
TOST icon
Toast
TOST
+$28.7M
4
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$26.8M
5
AXSM icon
Axsome Therapeutics
AXSM
+$25.9M

Top Sells

Rank Stock Value
1
DOCS icon
Doximity
DOCS
+$132M
2
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$74M
3
PANW icon
Palo Alto Networks
PANW
+$42.1M
4
XIFR
XPLR Infrastructure LP
XIFR
+$40M
5
APLS
Apellis Pharmaceuticals
APLS
+$36.2M

Sector Composition

Rank Sector Weight
1 Healthcare 41.13%
2 Technology 23.92%
3 Industrials 14.62%
4 Consumer Discretionary 8.5%
5 Energy 2.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NBIX icon
101
Neurocrine Biosciences
NBIX
$18.7B
$15.2M 0.27%
135,000
– –
SRPT icon
102
Sarepta Therapeutics
SRPT
$1.64B
$14.9M 0.27%
122,643
– –
BMRN icon
103
BioMarin Pharmaceuticals
BMRN
$11.7B
$14.5M 0.26%
164,299
– –
XENE icon
104
Xenon Pharmaceuticals
XENE
$6.2B
$14.1M 0.25%
413,906
– –
BCRX icon
105
BioCryst Pharmaceuticals
BCRX
$2.35B
$13.9M 0.25%
1,970,000
– –
VRNA
106
DELISTED
Verona Pharma
VRNA
$13.9M 0.25%
+850,000
New +$16.4M
ESI icon
107
Element Solutions
ESI
$8.68B
$13.4M 0.24%
683,780
+85,172
+14% +$1.69M
INZY
108
DELISTED
Inozyme Pharma
INZY
$13.1M 0.24%
+3,125,000
New +$15.9M
BRKR icon
109
Bruker
BRKR
$9.79B
$13.1M 0.24%
210,365
-10,438
-5% -$702K
GXO icon
110
GXO Logistics
GXO
$5.8B
$12.9M 0.23%
220,175
+13
+0% +$813
EQT icon
111
EQT Corp
EQT
$33B
$12.8M 0.23%
+316,200
New +$13.1M
DNLI icon
112
Denali Therapeutics
DNLI
$3.86B
$12.8M 0.23%
621,850
+308,443
+98% +$7.82M
RARE icon
113
Ultragenyx Pharmaceutical
RARE
$2.56B
$12.8M 0.23%
359,000
– –
IEX icon
114
IDEX
IEX
$17.3B
$12.1M 0.22%
58,292
-2,862
-5% -$621K
NTLA icon
115
Intellia Therapeutics
NTLA
$1.55B
$11.8M 0.21%
372,665
-120,557
-24% -$4.68M
EHC icon
116
Encompass Health
EHC
$11B
$11.4M 0.21%
170,108
-19,871
-10% -$1.37M
RCM
117
DELISTED
R1 RCM Inc. Common Stock
RCM
$11.1M 0.2%
735,705
– –
EGP icon
118
EastGroup Properties
EGP
$11.3B
$11.1M 0.2%
66,454
+33,199
+100% +$5.88M
ARDX icon
119
Ardelyx
ARDX
$1.25B
$11M 0.2%
+2,695,000
New +$10.5M
CERE
120
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$10.7M 0.19%
490,000
– –
KRRO icon
121
Korro Bio
KRRO
$151M
$10M 0.18%
+71,942
New +$1.8M
RVMD icon
122
Revolution Medicines
RVMD
$40.9B
$9.99M 0.18%
361,000
+365
+0.1% +$10.8K
MASS icon
123
908 Devices
MASS
$313M
$9.53M 0.17%
1,430,995
– –
IDYA icon
124
IDEAYA Biosciences
IDYA
$3.5B
$9.04M 0.16%
+335,000
New +$8.5M
VRSK icon
125
Verisk Analytics
VRSK
$26.1B
$8.95M 0.16%
37,881
-23,195
-38% -$5.47M
3 4
5
6 7

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2023 Portfolio in Review

As of Q3 2023, Eventide Asset Management held 166 positions worth $5.56B, down 6% from $5.92B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Eventide Asset Management's Q3 2023 filing shows 27 new, 60 increased, 40 reduced and 11 closed positions. Its largest new stake was monday.com: 203,617 shares worth $32.4M. The largest sale was Doximity, an estimated $132M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 44% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q3 2023 buy was monday.com: 203,617 shares worth $32.4M.
  • Eventide Asset Management added most to Transmedics in Q3 2023, an estimated $61.8M increase.
  • Eventide Asset Management's biggest Q3 2023 reduction was Palo Alto Networks, cutting an estimated $42.1M.
  • Eventide Asset Management fully exited Doximity in Q3 2023, selling an estimated $132M.
  • Eventide Asset Management's ten largest holdings make up 25% of its $5.56B portfolio in Q3 2023.
  • Eventide Asset Management opened 27 new positions and closed 11 in Q3 2023.
  • Eventide Asset Management's portfolio value fell 6% quarter-over-quarter to $5.56B.

Based on Eventide Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.